Evidence map›Paper›PMID 39259805›Full record

ArticleScience advances2024

Antibiotics damage the colonic mucus barrier in a microbiota-independent manner.

Jasmin Sawaed, Lilach Zelik, Yehonatan Levin, Rachel Feeney, Maria Naama, Ateret Gordon, Mor Zigdon, Elad Rubin, Shahar Telpaz, Sonia Modilevsky and 8 more

Abstract read
In one paragraph

Article in Science advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Nutrients · 2026
    Article
  10. Colonic epithelial regeneration shapes susceptibility tobioRxiv : the preprint server for biology · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. AbioRxiv : the preprint server for biology · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Jasmin SawaedAzrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.ORCID 0000-0002-5662-7051
Lilach ZelikAzrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.ORCID 0009-0008-3980-4491
Yehonatan LevinRacah Institute of Physics, The Hebrew University, Jerusalem, Israel.ORCID 0009-0009-8888-6371
Rachel FeeneyDepartment of Molecular Biology, Umeå University, Umeå, Sweden.ORCID 0000-0002-7686-6279
Maria NaamaAzrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.ORCID 0000-0002-9220-8938
Ateret GordonAzrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
Mor ZigdonAzrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
Elad RubinAzrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.ORCID 0009-0007-1141-3408
Shahar TelpazAzrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.ORCID 0000-0002-2469-8744
Sonia ModilevskyAzrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.ORCID 0000-0001-7120-5132
Shira Ben-SimonAzrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
Aya AwadAzrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.ORCID 0009-0006-4553-6345
Sarina Harshuk-ShabsoAzrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
Meital Nuriel-OhayonAzrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
Michal WerbnerAzrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
Bjoern O SchroederDepartment of Molecular Biology, Umeå University, Umeå, Sweden.ORCID 0000-0002-6716-8284
Amir ErezRacah Institute of Physics, The Hebrew University, Jerusalem, Israel.ORCID 0000-0002-2320-4984
Shai BelAzrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.ORCID 0000-0002-7166-4870

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibiotic use is a risk factor for development of inflammatory bowel diseases (IBDs). IBDs are characterized by a damaged mucus layer, which does not separate the intestinal epithelium from the microbiota. Here, we hypothesized that antibiotics affect the integrity of the mucus barrier, which allows bacterial penetrance and predisposes to intestinal inflammation. We found that antibiotic treatment led to breakdown of the colonic mucus barrier and penetration of bacteria into the mucus layer. Using fecal microbiota transplant, RNA sequencing followed by machine learning, ex vivo mucus secretion measurements, and antibiotic treatment of germ-free mice, we determined that antibiotics induce endoplasmic reticulum stress in the colon that inhibits colonic mucus secretion in a microbiota-independent manner. This antibiotic-induced mucus secretion flaw led to penetration of bacteria into the colonic mucus layer, translocation of microbial antigens into circulation, and exacerbation of ulcerations in a mouse model of IBD. Thus, antibiotic use might predispose to intestinal inflammation by impeding mucus production.

Indexed as

Anti-Bacterial AgentsColonGastrointestinal MicrobiomeIntestinal MucosaMucusAnimalsDisease Models, AnimalEndoplasmic Reticulum StressFecal Microbiota TransplantationHumansInflammatory Bowel DiseasesMiceMice, Inbred C57BLAnti-Bacterial Agents

Identifiers

PMID39259805
PMCPMC11389797

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.